Medistim

Director's Dealing • Jan 31, 2017

Transfer of shares to CEO Medistim ASA

Transfer of shares to CEO Medistim ASA

Medistim ASA has transferred 10,000 shares to Medistim

CEO Kari Krogstad as part of her compensation for

2017. It is part of her agreement with the Board of

Medistim that she receives 10,000 shares if she is in

position as CEO until 1st of January 2017. The

agreement has been previously described in the

Company's Annual Report. Medistims last traded share

price in 2016 was 73.50 so the shares are transferred

at this cost. Medistim ASA has 186,000 own shares and a

after the transfer to Kari Krogstad the company has

176,000 own shares shares.

Krogstad agreement gives her additional 12,500 shares

in Medistim if she is in position by end 2017. This is

also described in the latest Annual Report. The Board

of Medistim ASA has decided to award Kari Krogstad

with another 10,000 shares if she is in position as

CEO by end 2018.

Kari Krogstad has after the latest transfer 100,000

shares in Medistim ASA.